A Ureido-Thioisobutyric Acid (GW9578) Is a Subtype-Selective PPARα Agonist with Potent Lipid-Lowering Activity

This publication has 16 references indexed in Scilit:

• Peroxisome proliterator-activated receptor alpha in metabolic disease, inflammation, atherosclerosis and aging
  Current Opinion in Lipidology, 1999
• Treatment effects on serum lipoprotein lipids, apolipoproteins and low density lipoprotein particle size and relationships of lipoprotein variables to progression of coronary artery disease in the Bezafibrate Coronary Atherosclerosis Intervention Trial (BECAIT)
  Journal of the American College of Cardiology, 1998
• Peroxisome proliferator-activated receptor agonists
  Current Opinion in Chemical Biology, 1997
• Fatty acids and eicosanoids regulate gene expression through direct interactions with peroxisome proliferator-activated receptors α and γ
  Proceedings of the National Academy of Sciences, 1997
• Improved Insulin Sensitivity by Bezafibrate in Rats: Relationship to Fatty Acid Composition of Skeletal-Muscle Triglycerides
  Diabetes, 1997
• Mode of Action of Peroxisome Proliferators as Hypolipidemic Drugs.
  Journal of Biological Chemistry, 1995
• Fibrates downregulate apolipoprotein C-III expression independent of induction of peroxisomal acyl coenzyme A oxidase. A potential mechanism for the hypolipidemic action of fibrates.
  Journal of Clinical Investigation, 1995
• Lipoprotein Metabolism
  Drugs, 1994
• Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators
  Nature, 1990
• Apolipoproteins C-II and C-III metabolism in hypertriglyceridemic patients Effect of a drastic triglyceride reduction by combined diet restriction and fenofibrate administration
  Atherosclerosis, 1989